Table 1.
Characteristics | iTaukei |
Fijian of Indian Descent |
Pb |
---|---|---|---|
(n = 1212a) | (n = 802a) | ||
Male, n (%) | 511 (42.2) | 319 (39.8) | 0.29 |
Participant group, n (%) | 0.95 | ||
Young infants | 303 (25.0) | 193 (24.1) | |
Toddlers | 301 (24.8) | 197 (24.6) | |
Young children | 303 (25.0) | 207 (25.8) | |
Caregivers | 305 (25.2) | 205 (25.5) | |
Residence, n (%) | 0.29 | ||
Urban | 641 (52.9) | 405 (50.5) | |
Rural | 571 (47.1) | 397 (49.5) | |
Symptoms of URTI, n (%) | 393 (32.4) | 163 (20.3) | <0.01 |
Antibiotics in past fortnight, n (%) | 43 (3.6) | 18 (2.2) | 0.09 |
Exposure to household cigarette smoke, n (%) | 658 (54.3) | 429 (53.5) | 0.73 |
Povertyc, n (%) | 631 (52.1) | 426 (53.1) | 0.64 |
Household size, mean (95% CI) | |||
All ages | 8.1 (7.9, 8.3) | 5.7 (5.6, 5.8) | <0.01 |
Aged <18 years | 3.8 (3.7, 4.0) | 2.3 (2.2, 2.4) | <0.01 |
Aged <5 years | 2.1 (2.1, 2.2) | 1.4 (1.4, 1.5) | <0.01 |
PCV10 vaccinatedd, n %) | 375 (30.9) | 238 (29.7) | 0.55 |
Pneumococcal carriage, n/N; % (95% CI) | |||
Overalle | 538/1195; 45.0 (42.2, 47.9) | 108/797; 13.5 (11.2, 16.1) | <0.01 |
PCV10 serotypesf | 85/1182; 9.0 (7.5, 10.8) | 29/796; 3.6 (2.4, 5.2) | <0.01 |
Non-PCV10 serotypesg | 476/1182; 38.3 (35.5, 41.2) | 80/796; 10.0 (8.5, 12.3) | <0.01 |
Pneumococcal densityh n; median (IQR) | 538; 4.9 (4.0, 5.7) | 108; 4.7 (3.9, 5.5) | 0.16 |
URTI: upper respiratory tract infection.
Unless otherwise indicated.
2 test and t-tests compared categorical and continuous variables, respectively.
Family income <FJ$175/wk. [23].
Received at least two doses of PCV10.
Any pneumococci, including non-encapsulated pneumococci.
Pneumococci included in PCV10 (serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F).
Pneumococcal serotypes not included in PCV10, nor serotype 6A, including non-encapsulated pneumococci.
Includes only participants who were pneumococcal carriers.